Inhibition of the allergic response by regulatory T cells
- 1 February 2006
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Allergy and Clinical Immunology
- Vol. 6 (1) , 12-16
- https://doi.org/10.1097/01.all.0000200502.69672.44
Abstract
Allergic diseases are caused by the overdevelopment of T-helper type 2 biased immune responses in susceptible individuals. A number of recent studies indicate that regulatory T cells play an important role in controlling such T-helper type 2 biased responses not only in animal models, but in humans as well, and these will be reviewed in this article. A family of regulatory cells appears to be involved in regulating allergies. Both naturally occurring CD4CD25 regulatory T cells and inducible forms of antigen-specific regulatory T cells, both expressing the transcription factor foxp3, have been shown to inhibit the inappropriate immune responses involved in allergic diseases. Impaired expansion of natural or adaptive regulatory T cells is hypothesized to lead to the development of allergy, and treatment to induce allergen-specific regulatory T cells could provide curative therapies for allergy and asthma. Allergen-specific regulatory T cells play an important role in controlling the development of allergy and asthma.Keywords
This publication has 59 references indexed in Scilit:
- Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymusNature, 2005
- Mucosal immunity and allergic responses: lack of regulation and/or lack of microbial stimulation?Immunological Reviews, 2005
- Potential role of interleukin-10-secreting regulatory T cells in allergy and asthmaNature Reviews Immunology, 2005
- Cat allergen peptide immunotherapy reduces CD4+ T cell responses to cat allergen but does not alter suppression by CD4+ CD25+ T cells: a double‐blind placebo‐controlled studyAllergy, 2004
- Toll-like receptor signallingNature Reviews Immunology, 2004
- Selective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to immunostimulatory DNAJournal of Allergy and Clinical Immunology, 2004
- In Vivo Instruction of Suppressor Commitment in Naive T CellsThe Journal of Experimental Medicine, 2004
- Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitisJournal of Allergy and Clinical Immunology, 2002
- Allergen Immunotherapy: Therapeutic Vaccines for Allergic DiseasesAnnals of Allergy, Asthma & Immunology, 1998
- Published by American Association for the Advancement of Science (AAAS) ,1994